NL-OMON55108招募中不适用
PredicTive value of FluoR-18 PSMA-1007 PET/CT and anti-3-[18F] FACBC PET/CT before PLND for lymph nodE staging in primary pRostate cancer - TRACER Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •1. Biopsy proven adenocarcinoma of the prostate;
- •2. Indication for (super)extended PLND (with or without (robot-assisted)
- •laparoscopic prostatectomy), in intermediate and high risk patients ( d*Ámico
- •score) with an MSKCC >5% lymph node prediction;
- •3. Mentally competent and understanding of benefits and potential burden of the
- •4. Written informed consent;
- •5. Age >=18 years.
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •1. History of prior diagnosed or treated PCa.
- •2. Known concomitant malignancies (except Basal Cell Carcinoma of the skin).
- •3. Unwillingness or inability to undergo 18F-PSMA-1007 PET/CT and anti-3-[18F]
- •FACBC PET/CT, in combination with PLND.
- •4. Metastasis beyond pelvic region and/or bone metastasis. Patients with bone
- •metastasis will not get a PLND, but will be included in the study for further
- •follow-up.
研究者
相似试验
进行中（未招募）
1 期
PSMA vs FACBC compared to PLND for lymph node staging in primary prostate cancerProstate cancer (PCa) is the most common malignancy amongst men in Westerncountries. In order to select the most suitable treatment for patients diagnosed with PCa, it is importantto stage accurately. Both 18F-PSMA-1007 PET/CT and anti-3-[18F] FACBC PET/CT are currently mostly used to detectrecurrence in treated PCa, while the diagnostic value in detecting lymph node metastasis in primaryprostate cancer is not yet clear.EUCTR2019-004045-33-NLCatharina Hospital Eindhoven70
已完成
不适用
Clinical utility of [F-18]PSMA-1007 PET/CT (positron emission tomography/computed tomography) in evaluating preoperative staging of prostate cancer before radical prostatectomyKCT0004476Yonsei University Health System, Severance Hospital126
进行中（未招募）
1 期
Role of diagnostic imaging in the study of gliomas.Patients with high-grade glioma (III-IV).MedDRA version: 20.0Level: HLTClassification code 10018339Term: Gliomas benignSystem Organ Class: 100000004852EUCTR2015-000679-28-ITOSPEDALE SAN RAFFAELE20
招募中
不适用
Evaluation of the use of PET/CT in Adenoid Cystic Carcinoma (ADC)Adenoid Cystic CarcinomaRBR-84nmnm9Eduardo Nóbrega Pereira Lima
已完成
3 期
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate CancerProstate Cancer RecurrentProstate CancerNCT04742361ABX advanced biochemical compounds GmbH136